Daniel Baty

Responsable de groupe
Publications
Dec 2015 Antibodies (Basel, Switzerland)

Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?

Del Bano J, Chames P, Baty D, Kerfelec B

Apr 2019 Biophysical journal

Nanobody-CD16 Catch Bond Reveals NK Cell Mechanosensitivity.

González C, Chames P, Kerfelec B, Baty D, Robert P, Limozin L

Jan 2019 Frontiers in immunology

A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer.

Del Bano J, Florès-Florès R, Josselin E, Goubard A, Ganier L, Castellano R, Chames P, Baty D, Kerfelec B

Jul 2018 Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer.

Montemagno C, Bacot S, Ahmadi M, Kerfelec B, Baty D, Debiossat M, Soubies A, Perret P, Riou L, Fagret D, Broisat A, Ghezzi C

Mar 2018 Scientific reports

Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.

Ramos-Gomes F, Bode J, Sukhanova A, Bozrova SV, Saccomano M, Mitkovski M, Krueger JE, Wege AK, Stuehmer W, Samokhvalov PS, Baty D, Chames P, Nabiev I, Alves F

Dec 2017 Nature communications

Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation.

Scholler P, Nevoltris D, de Bundel D, Bossi S, Moreno-Delgado D, Rovira X, Møller TC, El Moustaine D, Mathieu M, Blanc E, McLean H, Dupuis E, Mathis G, Trinquet E, Daniel H, Valjent E, Baty D, Chames P, Rondard P, Pin JP

Mar 2016 Journal of acquired immune deficiency syndromes (1999)

V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.

Morgand M, Bouvin-Pley M, Plantier JC, Moreau A, Alessandri E, Simon F, Pace CS, Pancera M, Ho DD, Poignard P, Bjorkman PJ, Mouquet H, Nussenzweig MC, Kwong PD, Baty D, Chames P, Braibant M, Barin F

Feb 2016 Scientific reports

In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.

Krüwel T, Nevoltris D, Bode J, Dullin C, Baty D, Chames P, Alves F

Jul 2015 Journal of biomedical nanotechnology

Anti-Mesothelin Nanobodies for Both Conventional and Nanoparticle-Based Biomedical Applications.

Prantner AM, Turini M, Kerfelec B, Joshi S, Baty D, Chames P, Scholler N

Jun 2015 Analytical biochemistry

Detection of carcinoembryonic antigen using single-domain or full-size antibodies stained with quantum dot conjugates.

Rousserie G, Grinevich R, Brazhnik K, Even-Desrumeaux K, Reveil B, Tabary T, Chames P, Baty D, Cohen JH, Nabiev I, Sukhanova A

Feb 2015 ACS nano

Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.

Nevoltris D, Lombard B, Dupuis E, Mathis G, Chames P, Baty D

Dec 2014 Journal of virology

Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies.

Bouvin-Pley M, Morgand M, Meyer L, Goujard C, Moreau A, Mouquet H, Nussenzweig M, Pace C, Ho D, Bjorkman PJ, Baty D, Chames P, Pancera M, Kwong PD, Poignard P, Barin F, Braibant M

Nov 2014 Nanomedicine : nanotechnology, biology, and medicine

Multiphoton imaging of tumor biomarkers with conjugates of single-domain antibodies and quantum dots.

Hafian H, Sukhanova A, Turini M, Chames P, Baty D, Pluot M, Cohen JH, Nabiev I, Millot JM